Numerous pre-clinical studies have demonstrated that MSCs can regulate the differentiation of CD4+T cell subsets by limiting Th17 cell proliferation and promoting Treg production and immunosuppressive capacity, thereby regulating immune disorders, counteracting autoimmune responses in EAE, and ultimately maintaining immune tolerance [44]. Here, CD4 is linked to immune system disorder.